3694161\\n\\t\\n\\n\\n\\n##US GAAP Taxonomy\\n[Concept Core]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\nLabel: Concentration Risk Benchmark [Axis]\\nType: xbrli:stringItemType | Balance: None | PeriodType: duration | Abstract: True\\nStatus: None | DeprecatedLabel: None | DeprecatedDate: None\\nDocumentation:\\nInformation by benchmark of concentration risk.\\n\\nProvenance: file=GAAP_Taxonomy_2023.xlsx | sheet=Concepts | row=6131\\n\\n\\n[Concept Core]\\nID: us-gaap:TradeAccountsReceivableMember\\nLabel: Trade Accounts Receivable [Member]\\nType: dtr-types:domainItemType | Balance: None | PeriodType: duration | Abstract: True\\nStatus: None | DeprecatedLabel: None | DeprecatedDate: None\\nDocumentation:\\nAmount due from customers or clients for goods or services that have been delivered or sold in the normal course of business.\\n\\nProvenance: file=GAAP_Taxonomy_2023.xlsx | sheet=Concepts | row=8191\\n\\n\\n[Concept Core]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\nLabel: Concentration Risk Type [Axis]\\nType: xbrli:stringItemType | Balance: None | PeriodType: duration | Abstract: True\\nStatus: None | DeprecatedLabel: None | DeprecatedDate: None\\nDocumentation:\\nInformation by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.\\n\\nProvenance: file=GAAP_Taxonomy_2023.xlsx | sheet=Concepts | row=915\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:TradeAccountsReceivableMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Receivable [Domain] > Trade Accounts Receivable [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:TradeAccountsReceivableMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ReceivableTypeDomain -> to=us-gaap:TradeAccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ReceivableTypeDomain -> to=us-gaap:TradeAccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:TradeAccountsReceivableMember\\n\\nReferences:\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n \""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:TradeAccountsReceivableMember', 'us-gaap:ConcentrationRiskByTypeAxis=ktel:CustomerOneMember']\""},"id":{"kind":"number","value":89,"string":"89"}}},{"rowIdx":90,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n \\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\t 00000040 - Disclosure - MAJOR CUSTOMERS AND SUPPLIERS (Sales) (Details) \\n\\t link:presentationLink \\n\\t link:calculationLink \\n\\t link:definitionLink \\n\\t \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Customer Concentration Risk [Member] \\n \\n \\n Sales [Member] \\n \\n \\n Accounts Receivable [Member] \\n \\n \\n Concentration Risk [Line Items] \\n \\n \\n Customer Concentration Risk 3 [Member] \\n \\n \\n Supplier Concentration Risk [Member] \\n \\n \\n Concentration Risk [Table] \\n \\n \\n Percentage of concentrations risk \\n \\n \\n Three Suppliers [Member] \\n \\n \\n Concentration Risk Benchmark [Axis] \\n \\n \\n \\n Customer Concentration Risk 2 [Member] \\n Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. \\n \\n \\n Net sales \\n \\n \\n Two Suppliers [Member] \\n \\n \\n Risks and Uncertainties [Abstract] \\n \\n \\n Concentration Risk Type [Axis] \\n \\n \\n \\n Customer Concentration Risk 1 [Member] \\n Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk3Member \\n \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk3Member \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-10-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk3Member \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk3Member \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2020-07-01 \\n 2021-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2020-07-01 \\n 2021-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2020-07-01 \\n 2021-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2020-07-01 \\n 2021-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:TwoSuppliersMember \\n \\n \\n \\n 2021-07-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:ThreeSuppliersMember \\n \\n \\n \\n 2020-07-01 \\n 2020-12-31 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:ThreeSuppliersMember \\n \\n \\n \\n 2020-10-01 \\n 2020-12-31 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t10173000 \\n\\t8265000 \\n\\t20161000 \\n\\t16855000 \\n\\t10173000 \\n\\t8265000 \\n\\t6723000 \\n\\t5809000 \\n\\t1249000 \\n\\t1221000 \\n\\t1090000 \\n\\t658000 \\n\\t9062000 \\n\\t7688000 \\n\\t20161000 \\n\\t16855000 \\n\\t13714000 \\n\\t10978000 \\n\\t2189000 \\n\\t3391000 \\n\\t1970000 \\n\\t1127000 \\n\\t17873000 \\n\\t15496000 \\n\\t1 \\n\\t1 \\n\\t0.66 \\n\\t0.70 \\n\\t0.12 \\n\\t0.15 \\n\\t0.11 \\n\\t0.08 \\n\\t0.89 \\n\\t0.93 \\n\\t1 \\n\\t1 \\n\\t0.68 \\n\\t0.65 \\n\\t0.11 \\n\\t0.20 \\n\\t0.10 \\n\\t0.07 \\n\\t0.89 \\n\\t0.92 \\n\\t1 \\n\\t1 \\n\\t0.68 \\n\\t0.61 \\n\\t0.10 \\n\\t0.34 \\n\\t0.78 \\n\\t0.95 \\n\\t0.10 \\n\\t0.10 \\n\\t0.10 \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 9954515 - Disclosure - Investment in Loans (Schedule of Commercial Loans: Geographic Distribution) (Details) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Royal Bank of Canada [Member] \\n Royal Bank of Canada [Member] \\n Royal Bank of Canada [Member] \\n \\n \\n Due From Broker [Member] \\n Due From Broker [Member] \\n Due From Broker [Member] \\n \\n \\n Fair Value, Concentration of Risk, Maximum Amount of Loss \\n Fair Value, Concentration of Risk, Maximum Amount of Loss [Member] \\n \\n \\n MASSACHUSETTS \\n MASSACHUSETTS \\n \\n \\n Geographic Concentration Risk [Member] \\n Geographic Concentration Risk [Member] \\n \\n \\n Concentration Risk Benchmark [Axis] \\n Concentration Risk Benchmark [Axis] \\n \\n \\n NEW JERSEY \\n MASSACHUSETTS \\n NEW JERSEY \\n \\n \\n Tennessee [Member] \\n TENNESSEE \\n \\n \\n RHODE ISLAND \\n RHODE ISLAND \\n \\n \\n NEW HAMPSHIRE \\n NEW HAMPSHIRE \\n \\n \\n Receivables [Abstract] \\n Receivables [Abstract] \\n \\n \\n NORTH CAROLINA \\n MISSOURI \\n \\n \\n MICHIGAN \\n MICHIGAN \\n \\n \\n WASHINGTON \\n WASHINGTON \\n \\n \\n OHIO \\n OHIO \\n \\n \\n MARYLAND \\n MARYLAND \\n \\n \\n Residential mortgage loans \\n Residential Mortgage [Member] \\n \\n \\n Counterparty Risk [Member] \\n Credit Concentration Risk [Member] \\n \\n \\n Concentration Risk Type [Domain] \\n Concentration Risk Type [Domain] \\n \\n \\n ARIZONA \\n ARIZONA \\n \\n \\n GEORGIA \\n GEORGIA \\n \\n \\n Colorado [Member] \\n COLORADO \\n \\n \\n NEVADA \\n NEVADA \\n \\n \\n Collateral On Repurchase Agreements Held By Dealers [Member] \\n Collateral On Repurchase Agreements [Member] \\n Collateral On Repurchase Agreements [Member] \\n \\n \\n CALIFORNIA \\n CALIFORNIA \\n \\n \\n Geographical [Domain] \\n Geographical [Domain] \\n \\n \\n Other [Member] \\n Other States [Member] \\n Other States [Member] \\n \\n \\n Concentration Risk Type [Axis] \\n Concentration Risk Type [Axis] \\n \\n \\n Nomura Holdings Inc. \\n Nomura Holdings Inc. [Member] \\n Nomura Holdings Inc. \\n \\n \\n Commercial mortgage loans \\n Commercial Mortgage Loans [Member] \\n Commercial Mortgage Loans [Member] \\n \\n \\n SOUTH CAROLINA \\n SOUTH CAROLINA \\n \\n \\n Cash and Cash Equivalents [Member] \\n Cash and Cash Equivalents [Member] \\n \\n \\n CONNECTICUT \\n CONNECTICUT \\n \\n \\n ALABAMA \\n ALABAMA \\n \\n \\n NEW JERSEY \\n PENNSYLVANIA \\n \\n \\n Texas [Member] \\n TEXAS\\n\\n##Instance document\\n\\n\\n\\t\\n \\n 0001411342 \\n \\n stpr:CA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:FL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:FL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TX \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TX \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:UT \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:UT \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:AZ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:AZ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:PA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:PA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:GA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:GA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NC \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NC \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NJ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NJ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:IL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:IL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:WA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:WA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CO \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CO \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:MA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:MA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NV \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NV \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TN \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TN \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NY \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NY \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OR \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OR \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OH \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2023-01-01 \\n 2023-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OH \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CreditConcentrationRiskMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CreditConcentrationRiskMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CashAndCashEquivalentsMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SummaryOfInvestmentHoldings\\n Path: Securities Investment [Member] > Cash and Cash Equivalents [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Asset Class [Domain] > Cash and Cash Equivalents [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Cash and Cash Equivalents [Member] > Cash [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Cash and Cash Equivalents [Member] > Cash Equivalents [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CashAndCashEquivalentsMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SecuritiesInvestmentMember -> to=us-gaap:CashAndCashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/SummaryOfInvestmentHoldingsSummaryOfInvestmentHoldingsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SecuritiesInvestmentMember -> to=us-gaap:CashAndCashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/SummaryOfInvestmentHoldingsSummaryOfInvestmentHoldingsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:CashAndCashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:CashAndCashEquivalentsMember -> to=us-gaap:CashMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:CashAndCashEquivalentsMember -> to=us-gaap:CashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:CashAndCashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:CashAndCashEquivalentsMember -> to=us-gaap:CashMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:CashAndCashEquivalentsMember -> to=us-gaap:CashEquivalentsMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CashAndCashEquivalentsMember\\n\\nReferences:\\n- None | None | Element is not intended to be used with axis element identified in tin-part:AlternateElement. Member element intended to be used with axis element identified in tin-part:AlternateElement is identified in tin-part:AlternateElement.\\nProvenance: sheets include Reference-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n \""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByTypeAxis=us-gaap:CreditConcentrationRiskMember', 'us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:CashAndCashEquivalentsMember']\""},"id":{"kind":"number","value":91,"string":"91"}}},{"rowIdx":92,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n \\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\t 00000026 - Disclosure - CONCENTRATIONS OF CREDIT RISK AND ECONOMIC DEPENDENCE (Details) \\n\\t link:presentationLink \\n\\t link:calculationLink \\n\\t link:definitionLink \\n\\t \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Geographic Distribution, Domestic [Member] \\n \\n \\n Concentration Risk [Line Items] \\n \\n \\n Cost of Goods and Service Benchmark [Member] \\n \\n \\n Geographic Concentration Risk [Member] \\n \\n \\n Concentration Risk Benchmark [Axis] \\n \\n \\n Gross Accounts Receivable \\n \\n \\n Vendor B [Member] \\n \\n \\n Revenue Benchmark [Member] \\n \\n \\n Customer Concentration Risk [Member] \\n \\n \\n Geographic Distribution [Axis] \\n \\n \\n Customer A [Member] \\n \\n \\n One Vendor [Member] \\n \\n \\n Concentration Risk Type [Axis] \\n \\n \\n Vendor A [Member] \\n \\n \\n Geographic Distribution, Foreign [Member] \\n \\n \\n Customer B [Member] \\n \\n \\n Two Vendor [Member] \\n \\n \\n Capstone Brand [Member] \\n \\n \\n Supplier Concentration Risk [Member] \\n \\n \\n Concentration Risk [Table] \\n \\n \\n Smart Mirror Products U S [Member] \\n \\n \\n \\n Accounts payable \\n Accounts Payable \\n \\n \\n Accounts Payable [Member] \\n \\n \\n \\n Percentage of revenue \\n Concentration risk percentage \\n \\n \\n Product and Service [Axis] \\n \\n \\n Risks and Uncertainties [Abstract] \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n us-gaap:GeographicDistributionDomesticMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n us-gaap:GeographicDistributionDomesticMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n CAPC:SmartMirrorProductsUSMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n CAPC:SmartMirrorProductsUSMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n us-gaap:GeographicDistributionForeignMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n us-gaap:GeographicDistributionForeignMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CapstoneBrandMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:GeographicConcentrationRiskMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:GeographicConcentrationRiskMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n CAPC:CustomerConcentrationRiskOneMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n CAPC:CustomerConcentrationRiskOneMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n CAPC:CustomerConcentrationRiskTwoMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n CAPC:CustomerConcentrationRiskTwoMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskThreeMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskFourMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskThreeMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskFourMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:AccountsPayableMember \\n CAPC:SupplierConcentrationRiskThreeMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:AccountsPayableMember \\n CAPC:SupplierConcentrationRiskThreeMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskTwoMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n CAPC:SupplierConcentrationRiskTwoMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CostOfGoodsTotalMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2021-01-01 \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CustomerConcentrationRiskOneMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CustomerConcentrationRiskOneMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CustomerConcentrationRiskTwoMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:CustomerConcentrationRiskTwoMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:SupplierConcentrationRiskTwoMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:SupplierConcentrationRiskTwoMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n CAPC:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000814926 \\n \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2021-12-31 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t0.66 \\n\\t0.49 \\n\\t0.13 \\n\\t0.01 \\n\\t0.21 \\n\\t0.50 \\n\\t1 \\n\\t1 \\n\\t0.13 \\n\\t0.50 \\n\\t0.58 \\n\\t0.50 \\n\\t0.13 \\n\\t0.37 \\n\\t0.71 \\n\\t0.87 \\n\\t0.73 \\n\\t0.22 \\n\\t0.59 \\n\\t0.23 \\n\\t0.08 \\n\\t0.73 \\n\\t0.73 \\n\\t0.59 \\n\\t0.22 \\n\\t0.23 \\n\\t0.95 \\n\\t0.82 \\n\\t Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:SalesRevenueNetMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Domain] > Revenue Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Domain] > Revenue Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Revenue Benchmark [Member] > Revenue, Product and Service Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Revenue Benchmark [Member] > Revenue, Segment Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Revenue Benchmark [Member] > Revenue from Contract with Customer Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Domain] > Revenue Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Domain] > Revenue Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Revenue Benchmark [Member] > Revenue, Product and Service Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Revenue Benchmark [Member] > Revenue, Segment Benchmark [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Revenue Benchmark [Member] > Revenue from Contract with Customer Benchmark [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:SalesRevenueNetMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueProductLineMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueSegmentMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:RevenueFromContractWithCustomerMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueProductLineMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueSegmentMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:RevenueFromContractWithCustomerMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueProductLineMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueSegmentMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:RevenueFromContractWithCustomerMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:SalesRevenueNetMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueProductLineMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:SalesRevenueSegmentMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:SalesRevenueNetMember -> to=us-gaap:RevenueFromContractWithCustomerMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:GeographicConcentrationRiskMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Domain] > Geographic Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Domain] > Geographic Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Domain] > Geographic Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Domain] > Geographic Concentration Risk [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:GeographicConcentrationRiskMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:GeographicConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:GeographicConcentrationRiskMember\\n\\nReferences:\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n \""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueNetMember', 'us-gaap:ConcentrationRiskByTypeAxis=us-gaap:GeographicConcentrationRiskMember']\""},"id":{"kind":"number","value":92,"string":"92"}}},{"rowIdx":93,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n \\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 0000079 - Disclosure - Investment in Loans (Schedule of Commercial Loans: Geographic Distribution) (Details) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Royal Bank of Canada [Member] \\n Royal Bank of Canada [Member] \\n Royal Bank of Canada [Member] \\n \\n \\n Due From Broker [Member] \\n Due From Broker [Member] \\n Due From Broker [Member] \\n \\n \\n Fair Value, Concentration of Risk, Maximum Amount of Loss \\n Fair Value, Concentration of Risk, Maximum Amount of Loss [Member] \\n \\n \\n MASSACHUSETTS \\n MASSACHUSETTS \\n \\n \\n Geographic Concentration Risk [Member] \\n Geographic Concentration Risk [Member] \\n \\n \\n Concentration Risk Benchmark [Axis] \\n Concentration Risk Benchmark [Axis] \\n \\n \\n NEW JERSEY \\n MASSACHUSETTS \\n NEW JERSEY \\n \\n \\n Tennessee [Member] \\n TENNESSEE \\n \\n \\n RHODE ISLAND \\n RHODE ISLAND \\n \\n \\n NEW HAMPSHIRE \\n NEW HAMPSHIRE \\n \\n \\n NORTH CAROLINA \\n MISSOURI \\n \\n \\n Receivables [Abstract] \\n Receivables [Abstract] \\n \\n \\n MICHIGAN \\n MICHIGAN \\n \\n \\n WASHINGTON \\n WASHINGTON \\n \\n \\n OHIO \\n OHIO \\n \\n \\n MARYLAND \\n MARYLAND \\n \\n \\n Residential mortgage loans \\n Residential Mortgage [Member] \\n \\n \\n Counterparty Risk [Member] \\n Credit Concentration Risk [Member] \\n \\n \\n Concentration Risk Type [Domain] \\n Concentration Risk Type [Domain] \\n \\n \\n ARIZONA \\n ARIZONA \\n \\n \\n GEORGIA \\n GEORGIA \\n \\n \\n NEVADA \\n NEVADA \\n \\n \\n Colorado [Member] \\n COLORADO \\n \\n \\n Collateral On Repurchase Agreements Held By Dealers [Member] \\n Collateral On Repurchase Agreements [Member] \\n Collateral On Repurchase Agreements [Member] \\n \\n \\n CALIFORNIA \\n CALIFORNIA \\n \\n \\n Geographical [Domain] \\n Geographical [Domain] \\n \\n \\n Other [Member] \\n Other States [Member] \\n Other States [Member] \\n \\n \\n Concentration Risk Type [Axis] \\n Concentration Risk Type [Axis] \\n \\n \\n Nomura Holdings Inc. \\n Nomura Holdings Inc. [Member] \\n Nomura Holdings Inc. \\n \\n \\n Commercial mortgage loans \\n Commercial Mortgage Loans [Member] \\n Commercial Mortgage Loans [Member] \\n \\n \\n SOUTH CAROLINA \\n SOUTH CAROLINA \\n \\n \\n Cash and Cash Equivalents [Member] \\n Cash and Cash Equivalents [Member] \\n \\n \\n CONNECTICUT \\n CONNECTICUT \\n \\n \\n NEW JERSEY \\n PENNSYLVANIA \\n \\n \\n Texas [Member] \\n TEXAS \\n \\n \\n \\n\\n\\t\\n \\n 0001411342 \\n \\n stpr:CA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:FL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:FL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TX \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TX \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:UT \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:UT \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:AZ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:AZ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NC \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NC \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:GA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:GA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:PA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:PA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TN \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:TN \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:MA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:MA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NV \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NV \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NJ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NJ \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CO \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:CO \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:WA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:WA \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:IL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:IL \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NY \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:NY \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OR \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0001411342 \\n \\n stpr:OR \\n efc:FinancingReceivablesUnpaidPrincipalBalanceMember \\n us-gaap:GeographicConcentrationRiskMember \\n us-gaap:ResidentialMortgageMember \\n \\n \\n \\n 2022-01-01 \\n 2022-03-31 \\n \\n \\n\\t Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CreditConcentrationRiskMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Domain] > Credit Concentration Risk [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:CreditConcentrationRiskMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskTypeDomain -> to=us-gaap:CreditConcentrationRiskMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Schedule of Accounts, Notes, Loans and Financing Receivable [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Schedule of Product Information [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\n- Reference Project:Taxonomy Technical Improvement | None | None\\nProvenance: sheets include Reference-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n \""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByTypeAxis=us-gaap:CreditConcentrationRiskMember', 'us-gaap:ConcentrationRiskByBenchmarkAxis=efc:ReceivableForSecuritiesSoldMember']\""},"id":{"kind":"number","value":93,"string":"93"}}},{"rowIdx":94,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n \\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Customer #1 \\n Customer #1 \\n \\n \\n Segments [Axis] \\n \\n \\n \\n Hosted Services \\n Hosted Services \\n \\n \\n Accounting Policies [Abstract] \\n \\n \\n Concentration risk \\n \\n \\n Trade Account Receivables \\n \\n \\n Concentration Risk Benchmark [Axis] \\n \\n \\n Antidilutive shares excluded from computation of diluted earnings per share \\n \\n \\n Revenue \\n \\n \\n \\n Mobile Services \\n Mobile Services \\n \\n \\n Product Information [Line Items] \\n \\n \\n Sales Revenue \\n \\n \\n Schedule of Product Information [Table] \\n \\n \\n Concentration Risk Type [Axis] \\n \\n \\n \\n Customer #2 \\n Customer #2 \\n \\n \\n Receivables, concentration \\n \\n\\t\\n \\n 0000845819 \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n \\n 2022-01-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:TradeAccountsReceivableMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2022-01-01 \\n 2022-12-31 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2023-04-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2023-04-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2022-04-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2022-04-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerOneMember \\n \\n \\n \\n 2022-01-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n us-gaap:SalesRevenueNetMember \\n ktel:CustomerTwoMember \\n \\n \\n \\n 2022-01-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n \\n 2023-04-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n \\n 2022-04-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:HostedServicesMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:MobileServicesMember \\n \\n \\n \\n 2023-01-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:HostedServicesMember \\n \\n \\n \\n 2023-04-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:MobileServicesMember \\n \\n \\n \\n 2023-04-01 \\n 2023-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:HostedServicesMember \\n \\n \\n \\n 2022-01-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:MobileServicesMember \\n \\n \\n \\n 2022-01-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:HostedServicesMember \\n \\n \\n \\n 2022-04-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000845819 \\n \\n ktel:MobileServicesMember \\n \\n \\n \\n 2022-04-01 \\n 2022-06-30 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t\\n ktel:Number \\n \\n\\t803480 \\n\\t2205473 \\n\\t942772 \\n\\t273982 \\n\\t859334 \\n\\t255136 \\n\\t0.657 \\n\\t0.191 \\n\\t0.570 \\n\\t0.169 \\n\\t0.568 \\n\\t0.162 \\n\\t0.646 \\n\\t0.178 \\n\\t0.564 \\n\\t0.169 \\n\\t0.614 \\n\\t0.195 \\n\\t4601426 \\n\\t5123097 \\n\\t8633145 \\n\\t9350954 \\n\\t2614769 \\n\\t745485 \\n\\t3310128 \\n\\t910574 \\n\\t4872883 \\n\\t1463062 \\n\\t5741697 \\n\\t1826412 \\n\\t2483918 \\n\\t6149227 \\n\\t1250987 \\n\\t3350439 \\n\\t2842594 \\n\\t6508360 \\n\\t1428936 \\n\\t3694161 \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\t 00000038 - Disclosure - MAJOR CUSTOMERS & SUPPLIERS (Sales) (Details) \\n\\t link:presentationLink \\n\\t link:calculationLink \\n\\t link:definitionLink \\n\\t \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Customer Concentration Risk [Member] \\n \\n \\n Sales [Member] \\n \\n \\n Accounts Receivable [Member] \\n \\n \\n \\n Purchase [Member] \\n Information related to purchase member. \\n \\n \\n \\n Supplier Concentration Risk One [Member] \\n Supplier Two [Member] \\n \\n \\n Concentration Risk [Line Items] \\n \\n \\n Supplier Concentration Risk [Member] \\n \\n \\n Concentration Risk [Table] \\n \\n \\n Percentage of concentrations risk \\n \\n \\n Concentration Risk Benchmark [Axis] \\n \\n \\n \\n Customer Concentration Risk 2 [Member] \\n Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. \\n \\n \\n \\n \\n Net sales \\n Total net sales \\n Total revenue \\n \\n \\n Risks and Uncertainties [Abstract] \\n \\n \\n Concentration Risk Type [Axis] \\n \\n \\n \\n Customer Concentration Risk 1 [Member] \\n Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:SalesMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:PurchaseMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:PurchaseMember \\n us-gaap:SupplierConcentrationRiskMember \\n \\n \\n \\n 2021-07-01 \\n 2021-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:PurchaseMember \\n pdex:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n pdex:PurchaseMember \\n pdex:SupplierConcentrationRiskOneMember \\n \\n \\n \\n 2021-07-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n \\n \\n \\n 2021-07-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk1Member \\n \\n \\n \\n 2021-07-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n pdex:CustomerConcentrationRisk2Member \\n \\n \\n \\n 2021-07-01 \\n 2022-06-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2022-07-01 \\n 2022-09-30 \\n \\n \\n\\t\\n \\n 0000788920 \\n \\n us-gaap:AccountsReceivableMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2021-07-01 \\n 2022-06-30 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t11087000 \\n\\t9988000 \\n\\t11087000 \\n\\t9988000 \\n\\t7481000 \\n\\t6991000 \\n\\t2156000 \\n\\t879000 \\n\\t9637000 \\n\\t7870000 \\n\\t0.10 \\n\\t0.10 \\n\\t1 \\n\\t1 \\n\\t0.68 \\n\\t0.70 \\n\\t0.19 \\n\\t0.09 \\n\\t0.87 \\n\\t0.79 \\n\\t0.10 \\n\\t0.10 \\n\\t1 \\n\\t1 \\n\\t0.82 \\n\\t0.75 \\n\\t0.17 \\n\\t0.14 \\n\\t0.99 \\n\\t0.89 \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 995575 - Disclosure - CUSTOMER CONCENTRATION (Details Narrative) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Customer Concentration \\n \\n \\n Product Concentration \\n \\n \\n Customer [Axis] \\n \\n \\n Risks and Uncertainties [Abstract] \\n \\n \\n Concentration Risk [Line Items] \\n \\n \\n \\n Shouguang Weidong Chemical Company Limited \\n Shouguang Weidong Chemical Company Limited \\n \\n \\n \\n \\n Percentage of total revenues \\n Percent of products sold to top five customers \\n Percent of materials purchased \\n \\n \\n \\n Amounts due from major customers \\n Amounts due from major customers. \\n \\n \\n Concentration Risk [Table] \\n \\n \\n Concentration Risk Benchmark [Axis] \\n \\n \\n \\n Shandong Brother Technology Limited \\n Shandong Brother Technology Limited \\n \\n \\n Cost of Goods \\n \\n \\n \\n Shandong Morui Chemical Company Limited \\n Shandong Morui Chemical Company Limited \\n \\n \\n Concentration Risk Type [Axis] \\n \\n \\n Revenue \\n \\n \\n \\n Shandong Shouguang Shenrunfa Marine Chemical Company Limited \\n Shandong Shouguang Shenrunfa Marine Chemical Company Limited \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongMoruiChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShouguangWeidongChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongBrotherTechnologyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongShouguangShenrunfaMarineChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongBrotherTechnologyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongMoruiChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShouguangWeidongChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n gure:ShandongShouguangShenrunfaMarineChemicalCompanyLimitedMember \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:CostOfGoodsProductLineMember \\n us-gaap:ProductConcentrationRiskMember \\n \\n \\n \\n 2024-01-01 \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:CostOfGoodsProductLineMember \\n us-gaap:ProductConcentrationRiskMember \\n \\n \\n \\n 2023-01-01 \\n 2023-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2024-03-31 \\n \\n \\n\\t\\n \\n 0000885462 \\n \\n us-gaap:SalesRevenueNetMember \\n us-gaap:CustomerConcentrationRiskMember \\n \\n \\n \\n 2023-03-31 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t\\n utr:sqkm \\n \\n\\t0.151 \\n\\t0.123 \\n\\t0.123 \\n\\t0.103 \\n\\t0.159 \\n\\t0.156 \\n\\t0.151 \\n\\t0.104 \\n\\t0.55 \\n\\t0.64 \\n\\t1 \\n\\t1 \\n\\t2803534 \\n\\t3492933 \\n\\t \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 0000079 - Disclosure - Investment in Loans (Schedule of Commercial Loans: Geographic Distribution) (Details) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n